BofA Securities: Maintains JD Health (06618.HK) target price of HK$57 and "Buy" rating
Zhitong Finance APP has learned that BofA Securities issued a research report stating that JD Health (06618.HK) experienced operational fluctuations in the third quarter, but its structural growth remains intact. The company's third-quarter revenue grew 17% year-on-year, better than expected, and the growth rate improved from 15% in the second quarter. The bank reiterated its "Buy" rating and maintained its target price of HK$57.
Latest

